Tumor News and Research

RSS

New findings offer hope for children with aggressive brain tumors

Findings published in Oncotarget offer new hope for children with highly aggressive brain tumors like atypical teratoid/rhabdoid tumor (AT/RT) and medulloblastoma.

28 Nov 2017

Invasive cells deploy a trick to squeeze through barriers

Invasive cells deploy a trick to break through tissues and spread to other parts of the body, researchers report.

28 Nov 2017

New cancer drug begins clinical trial in human patients with rare brain tumor

A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain.

28 Nov 2017

Study unveils new immunotherapeutic target against multiple myeloma

Osaka - In recent decades monoclonal antibody-based treatment of cancer has been established as one of the most successful therapeutic strategies for both solid tumors and blood cancers.

27 Nov 2017

Researchers explore new method of destroying tumor cells

Researchers from Lomonosov MSU Faculty of Biology have studied the stages of entosis, a process of cell death when one cell invades the other and gets digested inside of it. Entosis could become a new method of destroying cancer cells.

27 Nov 2017

Primary tumor-associated bacteria also present in metastatic sites, study finds

The same bacteria present in primary tumors of patients with colorectal cancer are also present in liver metastases, a new study finds.

23 Nov 2017

Antimalarial drugs could find another use as cancer treatments, study says

Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.

23 Nov 2017

Study uncovers key mechanism by which tumors develop resistance to radiation therapy

A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development.

23 Nov 2017

UVA researchers developing new tool to help cancer patients make complex care decisions

Researchers at the University of Virginia Cancer Center are developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options. And that tool could ultimately benefit not just those patients but a broad spectrum of patients making complex care decisions based on their tumor's genomic information.

23 Nov 2017

SITC releases first consensus recommendations on managing immunotherapy side effects

The first consensus recommendations on recognition and clinical management of immune-related side effects from cancer immunotherapy are published today in the Journal for ImmunoTherapy of Cancer.

22 Nov 2017

Small protein modification can trigger invasive properties of prostate cancer cells, research finds

A small protein modification can trigger the aggressive migratory and invasive properties of prostate cancer cells, according to new research published on the cover of Oncotarget. The findings give greater insight into how cancers can move from one location in the body to another, and could help develop more effective therapies in the future.

22 Nov 2017

Inflammatory processes triggered by lung cancer could cause pulmonary hypertension

Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart and Lung Research in Bad Nauheim and the German Center for Lung Research found after examining more than 500 patients.

22 Nov 2017

Study finds specific tumor environment that stimulates cancer cells to metastasize

A new study, conducted by a team of researchers from the University of California, San Diego, has identified how the environment surrounding a tumor can stimulate metastatic behavior in the individual cancer cells. Researchers found that the tumor cells activate a particular set of genes and begin to form blood vessel-like structures when they are confined in a densely packed environment.

22 Nov 2017

Oncologists find new biomarker for breast cancer having poor prognosis

With the support of the FWF, an oncologist found a biomarker for breast cancer having a poor prognosis and developed two viable methods to detect it in tissue samples.

22 Nov 2017

Scientists discover how tumor environment can trigger metastatic behavior in cancer cells

A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells.

22 Nov 2017

OBD presents results of immunotherapy studies at FNIH Biomarker Consortium Cancer Steering Committee’s annual meeting

Oxford BioDynamics Plc, a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, presented its latest results at the annual meeting of the Foundation for National Institute for Health Biomarker Consortium Cancer Steering Committee, held in Washington, DC on 6-7 November 2017.

22 Nov 2017

Research findings offer prime drug targets to treat rare liver cancer that strikes young people

After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar hepatocellular carcinoma (FL-HCC), which mainly strikes adolescents and young adults.

22 Nov 2017

Tumor News and Research

New findings offer hope for children with aggressive brain tumors

Invasive cells deploy a trick to squeeze through barriers

New cancer drug begins clinical trial in human patients with rare brain tumor

Study unveils new immunotherapeutic target against multiple myeloma

Researchers explore new method of destroying tumor cells

Primary tumor-associated bacteria also present in metastatic sites, study finds

Antimalarial drugs could find another use as cancer treatments, study says

Study uncovers key mechanism by which tumors develop resistance to radiation therapy

UVA researchers developing new tool to help cancer patients make complex care decisions

SITC releases first consensus recommendations on managing immunotherapy side effects

Small protein modification can trigger invasive properties of prostate cancer cells, research finds

Inflammatory processes triggered by lung cancer could cause pulmonary hypertension

Study finds specific tumor environment that stimulates cancer cells to metastasize

Oncologists find new biomarker for breast cancer having poor prognosis

Scientists discover how tumor environment can trigger metastatic behavior in cancer cells

OBD presents results of immunotherapy studies at FNIH Biomarker Consortium Cancer Steering Committee’s annual meeting

Research findings offer prime drug targets to treat rare liver cancer that strikes young people

Scientists show how diaper phantoms can improve tumor measurements

‘Chemo brain’ may start as tumors form and develop, suggests study

New mechanism in cancer cells to disarm attacking immune cells, study reveals

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News